DVA

DaVita Inc. NYQ · DVA

$236.97 +2.96 (+1.26%)

Extended · +1.89σ

+ Compare Open in Sniper

Mkt cap $15.2B

P/E 22.8

Day $233.36 – $238.53

52wk $103.48 – $239.64

Avg vol 0.9M

Beta 0.88

Div yld —

Next earnings 2026-08-05

Quick read

Plain English

DVA last traded at $236.97, up 1.3% on the day; that's in the upper part of its 52-week range ($103.48–$239.64). Right now it's trading above its recent average — momentum is positive, though some of the move may already be in the price.

The next scheduled earnings report (2026-08-05) is the biggest known catalyst on the calendar, and after a strong run, watch whether the price can hold its gains on quieter days.

A plain-English snapshot built from the data on this page — not investment advice. Always do your own research.

Today's read

Grading desk →

KC2 upper, +1.82 ATR from EMA21 — no notable pattern

Long —

score 19 · tech 19 / 80 · support 0 / 20

above KC1 lower, +1.82 ATR from EMA21 · no notable pattern

· Stochastic bull cross
· Aligned with breakout up (strong tailwind)

How this grade was earned

total 19 pts

Cycle position 6

Momentum 3

Market fit 10

Each bar shows how many points that factor added. The more points — and the more factors that agree — the higher the letter grade.

Short —

score 22 · tech 22 / 80 · support 0 / 20

KC2 upper, +1.82 ATR from EMA21 · no notable pattern

ℹ️ Stretched (KC2): stop is set a little wider to avoid a whipsaw, so the reward/risk reads a bit lower by design.

· KC2 upper stretch — standard mean-reversion tier
· Counter-trend short in breakout up

How this grade was earned

total 22 pts

Cycle position 22

Each bar shows how many points that factor added. The more points — and the more factors that agree — the higher the letter grade.

132-Day Trend Zones

Full chart →

21 EMA +1 ATR +2 ATR −2 ATR

—

O — H — L — C —

— —

Valuation & accounting

Valuation desk →

Our cash-flow model pegs fair value near $94.36 (fair range $94–$638); today's price sits 143% above that estimate. The model's verdict is “Overvalued” and accounting quality screens as Weak. Model estimates only — do your own due diligence.

Intrinsic (DCF)

$94.36

Fair-value range

$94.36 – $637.68

Margin of safety

-143%

Verdict

Overvalued

Accounting quality Weak

⚠ Debt exceeds cash
⚠ Quick ratio 0.98 (fragile)
⚠ Negative retained earnings
⚠ Receivables growing faster than revenue

Price implies ~13% growth (vs trailing rev yoy). Model estimate — do your own due diligence.

Key statistics

All statistics →

DVA is a $15.2 billion company, priced at 23× last year's earnings, and the stock is trading near the top of its 52-week range.

Mkt cap $15.2B

P/E ttm 22.8

Fwd P/E 13.8

Beta 0.88

Day range $233.36 – $238.53

52w range $103.48 – $239.64

Avg vol 0.9M

RSI(2) 87.3

ROE 81.0%

Net mgn 5.6%

FCF mgn 7.2%

Debt/Eq 12.61

Div yld —

Sector Healthcare

Industry Medical Care Facilities

Next earn 2026-08-05

52-week range · today's price

$103.48$239.64

More on DVA

Options idea

See more →

CALL $240 2026-08-21

$12.43

PUT $240 2026-08-21

$15.35

Earnings

See more →

Last reported: 2026-05-05
EPS (act / est): 2.87 / 2.33
Surprise: +23.2%
Next report: 2026-08-05

About

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis dialysis services; operates clinical laboratories that provide routine labo…